Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

by

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

View original article
Contributor: Rebecca Robbins and Reed Abelson